Velos' IND Accountability System Implemented at MD Anderson Cancer Center
Over 100 MD Anderson pharmacists and technicians across 15 dispensing pharmacies began using the Velos Internet-based software
Over 100 MD Anderson pharmacists and technicians across 15 dispensing pharmacies began using the Velos Internet-based software product in early September in approximately 1,000 active clinical trials to maintain drug accountability. In addition, more than 20 years of data from two previous electronic accountability systems was imported into the new system, covering over 1.6 million drug-patient transactions. The system was co-developed by MD Anderson-Velos over a multi-year period to support Investigational Pharmacy Services. The product includes the Velos Present Tense™ search engine that can sift through large volumes of data and generate standard as well as ad–hoc reports instantaneously. The system also generates metrics for pharmacy managers to assess daily operations and manage inventory.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
